Oral collagen improved skin elasticity in placebo-controlled trials

Collagen supplements have surged in popularity for skin, yet the category sits in a regulatory grey zone with little oversight of quality, absorption or efficacy. That leaves consumers relying on marketing unless the clinical trial evidence is gathered and weighed. This review set out to do exactly that: collect every randomised, placebo-controlled trial of oral collagen with a dermatological outcome and ask whether swallowing collagen actually changes measurable properties of skin, from elasticity and hydration to wound healing and visible ageing.

The authors searched the published literature for randomised, placebo-controlled trials of collagen supplementation in humans with skin-related outcomes, written in English, with no lower limit on publication year. Eleven studies met the criteria, covering 805 patients in total. Eight trials used collagen hydrolysate at 2.5 g to 10 g per day for 8 to 24 weeks, studying pressure ulcers, dry skin, skin ageing and cellulite. Two trials used collagen tripeptide at 3 g per day for 4 to 12 weeks, and one used collagen dipeptide.

The pooled picture was consistently positive: oral collagen supplementation increased skin elasticity, hydration and dermal collagen density. The tripeptide trials showed notable improvement in elasticity and hydration, and the dipeptide study suggested that anti-ageing efficacy scaled with the dipeptide content of the supplement. The hydrolysate trials supported use for wound healing and skin ageing. Safety looked reassuring, with no adverse events reported across the included trials. The authors describe the results as preliminary but promising for both short and long-term use.

This review pushes collagen for skin from pure marketing territory into a space with genuine, if early, randomised evidence behind it. The trials are few, small and varied in the type of collagen, the dose and the duration, which is why the authors stop short of firm conclusions. Key open questions include whether collagen helps in skin barrier diseases such as atopic dermatitis, and what the optimal dosing regimen looks like. Better regulation of supplement quality and absorption would also strengthen future work.

If you have written collagen off as pure hype, this is a reason to update: placebo-controlled trials, not just testimonials, have recorded improvements in skin elasticity, hydration and collagen density, with no reported harms. Equally, if you have seen it sold as settled science, the honest label is preliminary, because 11 smallish trials with varied products cannot say which formulation or dose delivers, or how large the visible difference really is. The evidence justifies curiosity rather than certainty.